Cohort profile: pediatric patients with Crohn’s disease qualified to biologic therapy
Journal Title: Postępy Nauk Medycznych - Year 2014, Vol 27, Issue 3
Abstract
Introduction. Treatment with modern therapies is an economic problem in every country. Therefore, there are therapeutic programs of National Health Fund (NHF) in Poland which enable to apply such expensive treatment. Currently, Polish NHF programs include biologic therapy with infliximab (IFX) for pediatric patients aged 6-18 years with severe Crohn’s disease (CD).Aim. The aim of this study was to describe the clinical profile of pediatric patients hospitalized in the Department of Gastroenterology, Hepatology and Feeding Disorders, Children’s Memorial Health Institute in Warsaw, who have been qualified to biologic therapy with either infliximab (IFX) or adalimumab (ADA).Material and methods. We have performed a retrospective analysis of 107 children age 13.0 ± 9.3 years diagnosed with CD and treated with IFX and/or ADA within the period of 8 year; time between 2005 and 2013. The data on patient’s demographics, including age, sex, and age at disease onset as well as on the course and behavior of CD have been collected.Results. One hundred and seven CD patients (M: 54, F: 53) aged 13.0 ± 9.3 years were analyzed. Eighty one children (75.7%) received IFX, 26 (24.3%) ADA, and 8 (7.5%) were treated with both agents. Mean disease duration was 5.5 ± 0.83 years. The most frequently found location of lesions was L3 (56.1%). Extraintestinal manifestations were reported in 18 patients (16.8%), and arthralgia/arthritis was the most frequently found condition among them (77.8%). The most frequently found complication were nutritional and growth disorders, observed in 10 patients (9.3%). Mean PCDAI score at qualification was (median± ) 52.5]±27.5. Mean SES-SD (median [interquartile range]) score at qualification was 1 (1.0-22.0).Conclusions. Pediatric patients qualified to biologic therapy have rather severe than moderate course of disease with high PCDAI score.
Authors and Affiliations
Edyta Szymańska, Maciej Dądalski, Grzegorz Oracz, Jarosław Kierkuś
Keywords
Related Articles
- EP ID EP54923
- DOI -
- Views 181
- Downloads 0
Skuteczność pojedynczej i podwójnej predonacji łącznej z pooperacyjnym odzyskiem krwi w operacjach skolioz
<b>Wstęp.</b> Autotransfuzja jest zalecana u pacjentów podlegających zabiegom chirurgicznym kręgosłupa jako uznany środek redukujący potrzebę transfuzji krwi obcej. Istnieje niedobór badań, kt...
Treatment of congenital clubfoot using Ponseti method with early application of plaster cast – our own experiences
Introduction. Clubfoot is, apart from hip displasia, the most common congenital developmental malformation. Each year over 100.000 newborns worldwide are affected by this defect (1, 2). In Poland the frequency is estimat...
Pregnancy in women with valvular heart disease
Pregnancy creates significant hemodynamic changes in the cardiovascular system following the hormonal changes and the impact of placental circulation. Coexisting valvular heart disease increases substantially and, althou...
Delirium jako problem wieku starszego w przebiegu chorób neurologicznych
Delirium jest złożonym zespołem neuropsychiatrycznym szczególnie często występującym u osób starszych z wcześniej obecnymi chorobami mózgu. Podstawowymi objawami tego zespołu są nagłe zmiany funkcji poznawczych współistn...
Ocena wpływu walproinianu sodu (VPA) na wydzielanie LH, FSH, PRL i TSH w hodowli pierwotnej komórek przedniego płata przysadki samic i samców szczura
Walproinian sodu (VPA) – lek stosowany w leczeniu padaczki, może wywoływać zaburzenia w układzie rozrodczym u ludzi. Długotrwałe podawanie VPA samicom szczura może przyczynić się do powstawania torbieli jaj...